New Advances in Cutaneous Lymphomas

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".

Deadline for manuscript submissions: 29 May 2024 | Viewed by 95

Special Issue Editor


E-Mail Website
Guest Editor
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA 91010, USA
Interests: lymphoma; T-cell lymphoma; cutaneous lymphoma; hematopoetic stem cell transplant

Special Issue Information

Dear Colleagues,

Cutaneous lymphomas are a group of rare cancers that originate in the skin's lymphocytes. In recent years, there have been significant advancements in our understanding and management of cutaneous lymphomas. For example, Immunotherapy has emerged as a promising treatment option for cutaneous lymphomas. By harnessing the power of the immune system, therapies such as immune checkpoint inhibitors and CAR-T cell therapy have shown promising results in clinical trials. These approaches aim to enhance the body's natural defenses against cancer cells and improve treatment outcomes. While progress has been made, there are still challenges in the diagnosis and management of cutaneous lymphomas, particularly in special populations such as pediatric patients and immunosuppressed individuals.

This Special Issue aims to provide a communication platform for cutaneous lymphomas. We encourage the submission of articles and reviews describing related, original research.

Prof. Dr. Jasmine M. Zain
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cutaneous T-cell lymphomas
  • cutaneous B-cell lymphomas
  • skin
  • immune checkpoint
  • cell therapy

Published Papers

This special issue is now open for submission.
Back to TopTop